As Losses Narrow, Is Zai Lab Finally Finding its Winning Formula?
The biotech breaks a cycle of widening losses as it shifts towards developing new drugs Key Takeaways: Zai Lab reported its loss shrank 65% in the first quarter of the…
RELATED ARTICLES
-
FAST NEWS: Zai Lab’s loss narrows on strengthening sales
9688.HK ZLAB.US -
FAST NEWS: Zai Lab’s loss narrows on growing revenue
ZLAB.US 9688.HK
-
Everest reaches new heights on growing drug sales
1952.HK
-
HBM gets health boost from drug licensing deals
2142.HK
- InSilico seeks IPO boost to get AI drugs over the line
